Immunomedics (IMMU) - moderated Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Immunomedics (IMMU) - moderated

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: scorman1	9/25/2024 4:23:42 PM
	7 Recommendations Recommended By Davidoff diaperdaddy erippetoe Gotrodelvy jhcimmu and 2 more members Read Replies (2) of 63324

SAVA price action.... with the closing of the first phase 3 within a week or two, there is still a huge short position, even tho 5million shares have been covered in the last month. The lending rate has dropped from 29% to around 22%, but at higher SP, still banking around $900/day, paid by shorts 2x. A gamma squeeze is in the offing, with the bar set so low by Biogen and Lilly. Lilly just signed on Japan as the only other market besides US. W/R to Biogen, they have such a wonderful drug first of which caused their SP to jump $20billion upon approval, just traded at a five year low showing how the market values their "gem". All SAVA has to produce is the equivalent of the phase 2, 2 year extension with no cogs loss and this is a winner.... our expectations of super responders puts it into a totally different domain. Anecdotal evidence is clear... if Hillary's father is still alive, then he has already gained 4 years of quality life.... unheard of with this disease.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next